19-53050002-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001191055.2(ERVV-2):āc.751C>Gā(p.Pro251Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,499,472 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000059 ( 0 hom., cov: 20)
Exomes š: 0.000062 ( 1 hom. )
Consequence
ERVV-2
NM_001191055.2 missense
NM_001191055.2 missense
Scores
1
2
9
Clinical Significance
Conservation
PhyloP100: 0.305
Genes affected
ERVV-2 (HGNC:39051): (endogenous retrovirus group V member 2, envelope) Many different human endogenous retrovirus (HERV) families are expressed in normal placental tissue at high levels, suggesting that HERVs are functionally important in reproduction. This gene is part of an HERV provirus on human chromosome 19 that has inactivating mutations in the gag and pol genes. This envelope glycoprotein gene appears to have been selectively preserved. The gene's protein product is expressed in the placenta and acts as a syncytin in Old World monkeys, but has lost the fusogenic activity in humans and other primate lineages. [provided by RefSeq, Jun 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053248346).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERVV-2 | NM_001191055.2 | c.751C>G | p.Pro251Ala | missense_variant | 2/2 | ENST00000601417.3 | NP_001177984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERVV-2 | ENST00000601417.3 | c.751C>G | p.Pro251Ala | missense_variant | 2/2 | 4 | NM_001191055.2 | ENSP00000472919.1 |
Frequencies
GnomAD3 genomes AF: 0.0000594 AC: 8AN: 134690Hom.: 0 Cov.: 20
GnomAD3 genomes
AF:
AC:
8
AN:
134690
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000154 AC: 20AN: 130212Hom.: 0 AF XY: 0.000141 AC XY: 10AN XY: 70998
GnomAD3 exomes
AF:
AC:
20
AN:
130212
Hom.:
AF XY:
AC XY:
10
AN XY:
70998
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000623 AC: 85AN: 1364684Hom.: 1 Cov.: 32 AF XY: 0.0000667 AC XY: 45AN XY: 674190
GnomAD4 exome
AF:
AC:
85
AN:
1364684
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
674190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000594 AC: 8AN: 134788Hom.: 0 Cov.: 20 AF XY: 0.0000614 AC XY: 4AN XY: 65186
GnomAD4 genome
AF:
AC:
8
AN:
134788
Hom.:
Cov.:
20
AF XY:
AC XY:
4
AN XY:
65186
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.751C>G (p.P251A) alteration is located in exon 2 (coding exon 1) of the ERVV-2 gene. This alteration results from a C to G substitution at nucleotide position 751, causing the proline (P) at amino acid position 251 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
Sift4G
Pathogenic
D
Vest4
MVP
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at